SEREVENT (salmeterol xinafoate)

**Product type:** Human Prescription Drug

**Active ingredient:** SALMETEROL XINAFOATE

**Strength:** 50 ug/1

**Dosage form:** Powder, Metered

**Route:** Oral; Respiratory (Inhalation)

**Labeler:** GlaxoSmithKline LLC

**Marketing category:** NDA (NDA020692)

**Pharmacologic class:** Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]